Frontiers in Pharmacology | Cardiovascular and Smooth Muscle Pharmacology

Review

Published on 18 Feb 2025

A review of recent advances in anesthetic drugs for patients undergoing cardiac surgery

in Cardiovascular and Smooth Muscle Pharmacology

Yutian Sun
Xiangyou Sun
Haibo Wu
Zhaoyang Xiao
Wei Luo

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1533162

1,299 views

Original Research

Published on 17 Feb 2025

Comparison of the effects of perioperative fentanyl and morphine use on the short-term prognosis of patients with cardiac surgery in the ICU

in Cardiovascular and Smooth Muscle Pharmacology

Jingtao Zhong
Runqian Sui
Jie Zi
Anbiao Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1453835

1,446 views

Review

Published on 14 Feb 2025

Current usage of inclisiran for cardiovascular diseases: overview of current clinical trials

in Cardiovascular and Smooth Muscle Pharmacology

Maan H. Harbi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1449712

1,323 views

Original Research

Published on 14 Feb 2025

Cinnamic acid alleviates hypertensive left ventricular hypertrophy by antagonizing the vasopressor activity and the pro-cardiac hypertrophic signaling of angiotensin II

in Cardiovascular and Smooth Muscle Pharmacology

Yimeng Cui
Yawei Yang
Xinmiao Tang
Peiwei Wang
Jingang Cui
Yu Chen
Teng Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1555991

718 views

Editorial

Published on 14 Feb 2025

Editorial: Reviews in cardiovascular pharmacology: 2023

in Cardiovascular and Smooth Muscle Pharmacology

Yusof Kamisah
Ismail Laher
Mas Rizky A. A. Syamsunarno

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1566159

565 views

Review

Published on 12 Feb 2025

MicroRNAs in atrial fibrillation – have we discovered the Holy Grail or opened a Pandora’s box?

in Cardiovascular and Smooth Muscle Pharmacology

Alkora Ioana Balan
Alina Scridon

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1535621

744 views
1 citation

Editorial

Published on 10 Feb 2025

Editorial: Exploring small molecule inhibitors in cardiovascular and cerebrovascular diseases

in Cardiovascular and Smooth Muscle Pharmacology

Basveshwar Gawali
Shweta Shrivastava
R. Uday Kumar
Satyendra Kumar Rajput
Manish Kumar Jeengar

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1559488

598 views

Review

Published on 06 Feb 2025

Role of ferroptosis in atrial fibrillation: a review

in Cardiovascular and Smooth Muscle Pharmacology

Shaowei Fan
Yuanhui Hu
Jingjing Shi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1362060

1,214 views

Review

Published on 05 Feb 2025

The interplay of ferroptosis and oxidative stress in the pathogenesis of aortic dissection

in Cardiovascular and Smooth Muscle Pharmacology

Zhaoshan Zhang
Haichao Wang
Xi Kan
Xiaozhao Zhang
Senping Xu
Jie Cai
Jiawei Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1519273

1,114 views

Original Research

Published on 31 Jan 2025

Mechanism of mTOR/RILP-regulated autophagic flux in increased susceptibility to myocardial ischemia-reperfusion in diabetic mice

in Cardiovascular and Smooth Muscle Pharmacology

Jiyao Zhao
Wei Shi
Yan Zheng
Junjie Wang
Muzhao Yuan
Yultuz Anwar
Yuxuan He
Haiping Ma
Jianjiang Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1506401

1,050 views

Original Research

Published on 30 Jan 2025

Mechanism of salvianolic phenolic acids and hawthorn triterpenic acids combination in intervening atherosclerosis: network pharmacology, molecular docking, and experimental validation

in Cardiovascular and Smooth Muscle Pharmacology

Qu Zhai
Shixi Shang
Zihan Zhang
Lihua Sun
Ying Huang
Shuyi Feng
Qian Wu
Haifeng Cui
Xiaolu Shi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1501846

1,122 views

Case Report

Published on 29 Jan 2025

From the right ventricle to the descending aorta: a Case Report of complex thrombotic events in a patient with nephrotic syndrome

in Cardiovascular and Smooth Muscle Pharmacology

Jiaojiao Chen
Longyin Zhu
Fen Zhou
Yuting Li
Tao Gu
Jing Xia

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1514801

786 views

Original Research

Published on 27 Jan 2025

Knockdown ATG5 gene by rAAV9 alleviates doxorubicin-induced cardiac toxicity by inhibiting GATA4 autophagic degradation

in Cardiovascular and Smooth Muscle Pharmacology

Ai-Li Xu
Zheng Shen
Shi-Hao Wang
Hai-Yun Luan
Yong Xu
Ze-Chun Kang
Zi-Qi Liao
Jie Liu
Xiao-Lei Duan
Wei-Hua Bian

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1496380

669 views

Original Research

Published on 27 Jan 2025

Adverse events in different administration routes of amiodarone: a pharmacovigilance study based on the FDA adverse event reporting system

in Cardiovascular and Smooth Muscle Pharmacology

Jingrong Yang
Mengfan You
Jingxin Wang
Rongfei Sun
Lili Han
Xiaonan Liu
Kaibin Niu
Kaidi Xing
Juanping Sun
Wenge Su

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1517616

1,093 views

Correction

Published on 22 Jan 2025

Corrigendum: Notoginsenoside R1 protects against diabetic cardiomyopathy through activating estrogen receptor α and its downstream signaling

in Cardiovascular and Smooth Muscle Pharmacology

Bin Zhang
Jingyi Zhang
Chenyang Zhang
Xuelian Zhang
Jingxue Ye
Shihuan Kuang
Guibo Sun
Xiaobo Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1488083

575 views

Original Research

Published on 15 Jan 2025

Drug-induced heart failure: a real-world pharmacovigilance study using the FDA adverse event reporting system database

in Cardiovascular and Smooth Muscle Pharmacology

Youqi Huang
Xiaowen Chen
Mingyu Chen
Yuze Lin
Bingqi Chen
Hongjin Gao
Min Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1523136

1,436 views